Insperity is spending this year buying back the profit it lost when medical inflation outran the markup it charges small and mid-sized employers. Chairman Paul Sarvadi has named margin recovery the top priority, and the second-quarter print finally showed the plan working on earnings even as the paid worksite-employee count, the volume engine of a professional employer organization, kept shrinking. Price is doing the work that hiring used to do. That is a deliberate trade, not an accident of mix.
The tension sits in the cost stack that a PEO cannot fully control. Benefits expense per covered employee is still rising, workers' compensation is no longer getting the same prior-year reserve gift it received a year ago, and the Workday partnership is a cash cost before it is a growth product. Corporate payroll and a February realignment that cut about four percent of non-sales roles are what made operating income turn positive. James Allison, the finance chief, credits pricing, benefit-plan redesign, and expense control as the three legs of the recovery. The missing fourth leg is new client volume.
Second-quarter revenue rose two percent while average paid worksite employees fell one percent to just over three hundred five thousand. Adjusted earnings reached thirty four cents a share, and the company lifted full-year adjusted earnings guidance into a band whose midpoint sits a bit above $2. The equity now trades near $50, a recovery from last year's low teens print, and it already capitalizes a completed turn rather than a still-shrinking book. Whether paid headcount stops falling in the second half, and whether HRScale converts Workday spend into enrollments, decides if this is a durable reset or a one-year earnings bounce on a smaller client base.